Trikafta 100-50-75 MG/150 MG UU 84S
Ended Awarded
- Contract number
- SPE2DB25FZX71
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,976
Award facts
- Contract value 100% obligated
- $36,976.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at approximately $37,000 by the Defense Logistics Agency on August 25, 2025, for the supply of Trikafta 100-50-75 mg/150 mg pharmaceutical product. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, was issued without a set-aside designation and represents a continuation of DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain. The award leverages the company's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at approximately $500 million and valid through November 2026, which enables the agency to issue delivery orders for comprehensive pharmaceutical products supporting military health facility needs.
DMS Pharmaceutical Group has demonstrated consistent success in securing federal pharmaceutical contracts with the Defense Logistics Agency, specializing in the distribution of branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare facilities nationwide. The company's contract portfolio reflects expertise in delivering specialized pharmaceutical products including oncology treatments, vaccines, auto-injectors, and other prescription medications essential to Department of Defense healthcare operations. This particular award underscores the company's established positioning as a preferred vendor for pharmaceutical supply to federal military medical systems.
Quick answers
Who was awarded contract SPE2DB25FZX71?
SPE2DB25FZX71 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FZX71 worth?
The government has obligated $36,976 on SPE2DB25FZX71.
Is contract SPE2DB25FZX71 an order under another contract?
Yes. SPE2DB25FZX71 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZX71 competed?
The extent of competition for SPE2DB25FZX71 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award